Phase 1 Chronic Kidney Disease(CKD) Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
Kidney Disease, ChronicChronic Kidney DiseaseKidney Disease+2 more
Adia Med of Winter Park LLC100 enrolled1 locationNCT07572890
Recruiting
Phase 1Phase 2
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals56 enrolled10 locationsNCT05092347
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability and PK of SK-08
Chronic Kidney Disease(CKD)
Consun Pharmaceutical Group48 enrolled1 locationNCT07021157